Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (112)
2025 (1350)
2024 (1422)
2023 (1383)
2022 (1484)
2021 (1501)
2020 (1305)
2019 (1146)
2018 (1213)
2017 (1101)
2016 (996)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (20)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (15538)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Spalinskas R
JSON
CSV
XLSX
TXT
Family name
Spalinskas
Given name
Rapolas
Initials
R
ORCID
ORCID
0000-0002-1648-6426
Affiliations
Science for Life Laboratory, Division of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
3 publications
PubMed
DOI
Crossref
Enhancer mutations modulate the severity of chemotherapy-induced myelosuppression.
Zhigulev A
, Norberg Z, Cordier J, ...,
Gréen H
,
Sahlén P
Life Sci. Alliance
7
(3) - [2024-03-00; online 2024-01-16]
PubMed
DOI
Crossref
Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients.
Björn N
,
Badam TVS
,
Spalinskas R
, ...,
Gustafsson M
, Gréen H
NPJ Syst Biol Appl
6
(1) 25 [2020-08-24; online 2020-08-24]
PubMed
DOI
Crossref
Allele specific chromatin signals, 3D interactions, and motif predictions for immune and B cell related diseases.
Cavalli M,
Baltzer N
, Umer HM, ..., Komorowski J, Wadelius C
Sci Rep
9
(1) 2695 [2019-02-25; online 2019-02-25]
SciLifeLab Data Centre
Publications
9.5.1